Investments → Case Study

Apollo Therapeutics

Apollo Therapeutics is rapidly advancing a robust pipeline of potentially transformative therapeutic programs by combining drug development ‘architects’ and deep subject matter experts who together are building an expansive and de-risked pipeline in oncology, major inflammatory disorders and rare disease.